Arcellx

Arcellx was founded by serial entrepreneur and former Human Genome Sciences VP David Hilbert. Arcellx is developing CAR-T technologies to tackle multiple myeloma with a more efficacious and calcitrant treatment than is currently available. Early success has allowed Arcellx and Kite Pharma (Frederick, MD) to enter into a co-development partnership.

Arcellx has been a model Maryland growth company. Having started in the Germantown Innovation Center, Arcellx moved to West Watkins Mill and is now repositioning an office building in Rockville. Today, Arcellx is planning a manufacturing facility in Frederick County after evaluating sites in Maryland and California, the home of Arcellx's CEO and CSO.

“Facility Logix assisted me in staying on top of everything as we transformed an old office into a new lab that would support R&D.”

- Michael Dombeck, Chief Operating Officer, Arcellx, Inc

Arcellx

Project Size: 100,000 SF (Phased)
Schedule: Jun 2022
# Of Employees: 135
Cost: Confidential
Location: Rockville, MD

“Facility Logix assisted me in staying on top of everything as we transformed an old office into a new lab that would support R&D.”

- Michael Dombeck, Chief Operating Officer, Arcellx, Inc